Claritev Corp Stock Price, News & Analysis

Claritev (NYSE:CTEV), a healthcare technology and data insights company, has published its 2024 Corporate Responsibility Report, highlighting its sustainability initiatives and social impact. The report outlines significant progress in healthcare accessibility, data security, and environmental stewardship.

Key achievements include completing their third greenhouse gas inventory, progressing toward 100% cloud storage migration by 2025, implementing enhanced employee benefits including 100% paid parental leave, and receiving multiple workplace recognitions. The company's partnership with the National Rural Health Association aims to extend healthcare technology access to underserved communities.

Claritev Corporation (NYSE: CTEV), a healthcare technology and data insights company, has scheduled its second quarter 2025 earnings release for Wednesday, August 6, 2025. The company will host a conference call at 8:00 am Eastern Time on the same day.

Participants can pre-register for the call through a provided link, after which they will receive calendar invitations with access details and unique PINs. A live webcast will be accessible through the company's Investor Relations website, where the earnings release and supplemental slide deck will also be available. For those unable to attend live, a replay will be available approximately two hours after the call.

Claritev (NYSE:CTEV) announced that its PHCS Network has received its 12th consecutive NCQA Accreditation in Credentialing. The PHCS Network, the largest primary PPO in the nation, is the only national independently contracted primary PPO with NCQA accreditation.

The accreditation is valid through June 13, 2028, following a rigorous review of credentialing processes. The PHCS Network serves nationwide with over 1 million participating practitioners, 4,600 acute care facilities, and 92,000 ancillaries.

Claritev Corporation (NYSE: CTEV), a healthcare technology company, has joined the Coalition for Health AI (CHAI), an industry-led alliance focused on developing best practices for healthcare AI innovation and safety. The company aims to collaborate with CHAI's diverse community of health systems, researchers, patient advocates, and technology leaders to establish frameworks for responsible AI development in healthcare. Fernando Schwartz, Claritev's Chief AI Officer, emphasized this partnership aligns with their mission of improving healthcare affordability and transparency through data-driven innovation. CHAI's CEO Brian Anderson welcomed Claritev, highlighting the importance of member engagement in advancing effective and responsible health AI. Claritev will contribute its healthcare data integration and analytics expertise to initiatives focusing on transparency, fairness, safety, and privacy in AI.

Claritev (NYSE: CTEV) is strengthening its presence in the Middle East North Africa (MENA) region through key strategic moves. The company has appointed Mohamed Ramzy as Senior Vice President and General Manager, International, who will report directly to CEO Travis Dalton and oversee MENA operations. Ramzy brings nearly 20 years of healthcare technology experience, previously serving as Country General Manager at Oracle Health.

Additionally, Claritev has established a strategic partnership with Halian, a global workforce and technology solutions provider, to manage its UAE operations including payroll, recruitment, and human capital administration. These initiatives follow Claritev's previous collaborations with Burjeel Holdings and Claims Care Revenue Cycle Management, reinforcing the company's commitment to expanding its international footprint and delivering localized healthcare technology solutions.

Claritev (NYSE: CTEV) and Claims Care Revenue Cycle Management, a division of Burjeel Holdings (ADX: BURJEEL), have formalized their strategic partnership to transform revenue cycle management in the MENA region. The collaboration combines Claritev's advanced claims analytics and AI-driven solutions with Claims Care's regional expertise.

Key partnership highlights include: accelerated product development for MENA-tailored RCM solutions, operational synergies through transitioning Claritev's offshore processes to Claims Care, enhanced healthcare delivery efficiency, and strategic market expansion. Claritev anticipates generating regional revenues during 2025.

Claritev Corporation (NYSE: CTEV) reported its Q1 2025 financial results with revenues of $231.3 million, representing a 1.4% decrease from Q1 2024. The company posted a net loss of $71.3 million, significantly improved from a $539.7 million loss in Q1 2024. Adjusted EBITDA reached $142.1 million with a 61.4% margin. Key developments include debt extension completion, rebranding to Claritev, and strategic partnerships with Oracle, J2 Health, and Burjeel Holdings. The company processed $42.9 billion in claim charges, identifying potential medical cost savings of $6.2 billion. Despite negative free cash flow of $(68.9) million, Claritev reaffirmed its full-year 2025 guidance, projecting revenue growth between -2% to flat and Adjusted EBITDA margin of 62.5-63.5%.

Claritev (NYSE: CTEV) has announced a strategic partnership with Lantern to enhance healthcare cost transparency and optimization. The collaboration integrates Claritev's BenInsights® and HST Connect® solutions with Lantern's Network of Excellence and TrueRate™ methodology. The partnership will focus on two key areas: Enhanced Data Analytics through BenInsights, providing comprehensive healthcare spending visibility, and Optimized Patient Steering via HST Connect, guiding patients to cost-effective, high-quality providers.

The partnership builds on previous joint research and aims to address surgical costs, which represent 20% of employer health spending. Through this collaboration, both companies aim to deliver meaningful savings for employer groups while improving patient care quality through data-driven surgical cost analysis.

Claritev Corporation (NYSE: CTEV) has appointed Jason Kap to its Board of Directors, effective immediately following his election at the Company's Annual Meeting on April 30, 2025. Kap brings over 20 years of leadership experience in technology, pricing, and product transformation strategies. He currently serves as CEO of Blue Rocket Incorporated and previously held leadership positions at Microsoft Corporation and Zipwire, Inc. The appointment aligns with Claritev's technology-driven transformation strategy in healthcare cost optimization and revenue integrity solutions.

As a visiting scholar at MIT (2013-2020) and with extensive board experience, Kap's expertise will support Claritev's mission to make healthcare more affordable, transparent, and fair through technology, data, and insights.